TDI-11055
Product Specifications
Target
Endogenous Metabolite
Related Pathways
Metabolism
Purity
0.9848
Bioactivity
TDI-11055 is an orally available inhibitor of chromatin reader 11-19 leukemia (ENL) that works by blocking the interaction of its YEATS domain with acylated histones. TDI-11055 can be used to study acute myeloid leukemia (AML) .
Smiles
C[C@@H](CCC1)N1CC2=CC3=C(N2)C=C(NC(C4=CC(C=NN5C)=C5C=C4)=O)N=C3
Molecular Formula
C22H24N6O
Molecular Weight
388.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6285854-01 0.2 mL
CHRNA5, ID (CHRNA5, NACHRA5, Neuronal acetylcholine receptor subunit alpha-5) (AP)
Sign In for Pricing
View Details MBS6285854-02 5x 0.2 mL
CHRNA5, ID (CHRNA5, NACHRA5, Neuronal acetylcholine receptor subunit alpha-5) (AP)
Sign In for Pricing
View Details